Immunogenicity Assessment for the Successful Development of Biosimilars
Dr Michael Tovey, Institut Andre Lwoff/INSERM, speaking at Stem Cells & Bioprocessing 2012.
Bicyclic Peptides with Antibody-Like Binding Affinity and Specificity
Dr Vanessa Baeriswyl, EPFL, speaking at Stem Cells & Bioprocessing Europe 2012.
Drug-induced Hepatotoxicity Prediction Using Three-Dimensional Culture Models in High Content Screening Context
Dr Thierry Dorval, Institut Pasteur Korea, speaking at European Laboratory Automation 2012.
Novel, Simple Technology for Creating Physiologically Relevant 3-D Tissue Models
Rosemary Drake, TAP Biosystems, speaking at European Laboratory Automation 2012.
An Integrated System Using Peptide Arrays to Assess Kinase and Nuclear Receptor Activities in Clinical Samples for Biomarker Development
Bertrand Jordan, Aix-Marseille University, speaking at Microarray World Congress 2012
Phenotypic Drug Screening: the Power of High Capacity Flow
Dr Kim Luu, Intellicyt, Inc., speaking at European Laboratory Automation 2012.
Joint Talk - Deciphering the Cell with GE Healthcare Cell Technologies / The Importance of High Content Analysis for Stem Cell Culture, Differentiation and Media Development
Dr. Bergendahl, Miltenyi Biotec GmbH, speaking at European Laboratory Automation 2012.
Actin' Out, Development of a High Content Screen Protocol for Investigation of the Interplay Between Epithelial Junctions and the Actin Cytoskeleton
Dr Ann Wheeler, Queen Mary University of London, speaking at European Laboratory Automation 2012.
siRNA Sequence Model: ReDesign Algorithm Based on Available Genome Wide Libraries Screens
Karol Kozak, Head, Computation Analysis, ETH Zurich, speaking at European Laboratory Automation 2012.